These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17577671)

  • 1. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
    Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
    Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance.
    Grayson AC; Cima MJ; Langer R
    Biomaterials; 2005 May; 26(14):2137-45. PubMed ID: 15576189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
    Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
    J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The construction of three-dimensional micro-fluidic scaffolds of biodegradable polymers by solvent vapor based bonding of micro-molded layers.
    Ryu W; Min SW; Hammerick KE; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
    Biomaterials; 2007 Feb; 28(6):1174-84. PubMed ID: 17126395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drug type on the degradation rate of PLGA matrices.
    Siegel SJ; Kahn JB; Metzger K; Winey KI; Werner K; Dan N
    Eur J Pharm Biopharm; 2006 Nov; 64(3):287-93. PubMed ID: 16949804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
    Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
    Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of sirolimus from a multilayered PLGA stent matrix.
    Wang X; Venkatraman SS; Boey FY; Loo JS; Tan LP
    Biomaterials; 2006 Nov; 27(32):5588-95. PubMed ID: 16879865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon dioxide extraction of residual chloroform from biodegradable polymers.
    Koegler WS; Patrick C; Cima MJ; Griffith LG
    J Biomed Mater Res; 2002; 63(5):567-76. PubMed ID: 12209902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet.
    Manome Y; Kobayashi T; Mori M; Suzuki R; Funamizu N; Akiyama N; Inoue S; Tabata Y; Watanabe M
    Anticancer Res; 2006; 26(5A):3317-26. PubMed ID: 17094447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
    Cho KY; Lee S; Park JK
    Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study of GDNF release from biodegradable PLGA microspheres.
    Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP
    J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
    Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
    Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acidic pH on PLGA microsphere degradation and release.
    Zolnik BS; Burgess DJ
    J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
    Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
    J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
    Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
    J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles.
    Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Gafa V; Chuburu F
    Nanotechnology; 2010 Apr; 21(16):165101. PubMed ID: 20348590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.